Regulation of shRNA adenovirus construction by tumor specific promoter Survivin and inhibitory effect of Survivin on expression of CD133 gene in HepG-2 cells
LI Fang,ZOU Dongling,CAO Shu,LI Shaolin
DOI: https://doi.org/10.11699/cyxb20131206
2013-01-01
Abstract:Objective:To construct small hairpin RNA driven by tumor specific promoter Survivin and to discuss the effects of down-regulating CD133 expression in HepG-2 cells line on proliferative and invasive ability of hepatoma cell. Methods:①pEntr-Sur-shRNA eukaryotic expression vector was built and HepG-2 cells,Hela cells and 293T cells were transfected. ②shRNA interference fragments were designed and CD133 interference fragments with the best effect were screened out. Carriers were reconstructed;Ad. Surp-shRNA972,Ad.Surp-shRNA485,Ad.Surp-shRNA2377 adenovirus were packed;stable expression of shRNA transfection cloning was screened out 972,2377,485 experimental groups were established by transfecting HepG-2 cells with Ad.Surp-shRNA972,Ad. Surp-shRNA2377,Ad.Surp-shRNA485;untransfected group was taken as blank control group RT-PCR and Western blot were used to test CD133 mRNA and protein expression;MTT and Transwell method were used to detect the proliferative and invasive ability of cell in vitro. Results:①Survivin promoter regulated shRNA eukaryotic expression vector of pEntr-Sur-shRNA was successful constructed. Fluorescence was seen in Hela and HepG-2 cells but not in 293T cells indicating tumor specificity of Survivin promoter. ② Adenovirus of Ad.Surp-shRNA972,Ad.Surp-shRNA2377 and Ad.Surp-shRNA485 were successfully packaged. ③According to results of RT-PCR and Western blot,mRNA and protein levels were inhibited significantly by Ad.Surp-shRNA972 and Ad.Surp-shRNA2377 mRNA inhibition rates were(63.44±0.02)% and(56.98±0.03)% in experiment group and blank group and protein inhibition rates were(55.43±0.40)%,(48.65±0.20)%,(34.67±0.40)% in Ad.Surp-shRNA972 group,Ad.Surp-shRNA2377 group and Ad.Surp-shRNA485 group. Cell proliferative and invasive abilities of cells in experiment group were inhibited with inhibition rates of(72.88±0.74)%,(59.9±0.87)% and(30.18±0.95)% in Ad.Surp-shRNA972 group,Ad.Surp-shRNA2377 group and Ad.Surp-shRNA485 group. Conclusions:Tumor specific promoter Survivin regulating adenovirus mediated shRNA can decrease CD133 suppression and inhibit proliferation and invasiveness of HepG-2 hepatoma cell.